Mitigating Health Risks of Prescription Drugs: Lessons From FDA Oversight of Opioid Products

JAMA. 2019 Feb 19;321(7):651-653. doi: 10.1001/jama.2019.0236.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Analgesics, Opioid
  • Fentanyl*
  • Prescription Drug Misuse
  • Prescription Drugs*
  • Risk Evaluation and Mitigation

Substances

  • Analgesics, Opioid
  • Prescription Drugs
  • Fentanyl